Efficacy and Safety of Caspofungin for Treatment of Invasive Aspergillosis in Patients Refractory to or Intolerant of Conventional Antifungal Therapy
Clinical Infectious Diseases2004Vol. 39(11), pp. 1563–1571
Citations Over TimeTop 1% of 2004 papers
J. Maertens, Issam Raad, G. Petrikkos, Marc Boogaerts, Dominik Selleslag, Finn Bo Petersen, Carole A. Sable, Nicholas A. Kartsonis, Angela Ngai, Arlene Taylor, Thomas F. Patterson, David W. Denning, Thomas J. Walsh, Caspofungin Salvage Aspergillosis Study Group
Abstract
Caspofungin demonstrated usefulness in the salvage treatment of IA.
Related Papers
- → Relative Frequency of Paradoxical Growth and Trailing Effect with Caspofungin, Micafungin, Anidulafungin, and the Novel Echinocandin Rezafungin against Candida Species(2020)16 cited
- → A comparative evaluation of properties and clinical efficacy of the echinocandins(2007)50 cited
- → The Postantifungal and Paradoxical Effects of Echinocandins Against Candida spp.(2012)12 cited
- → Medical Claims and Current Applications of the Potent Echinocandin Antifungals(2009)2 cited
- The role of caspofungin and the echinocandins in the antifungal armamentarium.(2002)